Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W R Gerritsen

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Cancer Gene Therapy|July 31, 2001
Selective gene delivery toward gastric and esophageal adenocarcinoma cells via EpCAM-targeted adenoviral vectorsD A Heideman, P J Snijders, M E Craanen, et al.
Blood|November 15, 1995
The value of flow cytometric analysis of platelet glycoprotein expression of CD34+ cells measured under conditions that prevent P-selectin-mediated binding of plateletsM W Dercksen, I S Weimar, D J Richel, et al.
British Journal of Cancer|June 1, 2006
Different susceptibility of osteosarcoma cell lines and primary cells to treatment with oncolytic adenovirus and doxorubicin or cisplatinH C A Graat, M A Witlox, F H E Schagen, et al.
Anticancer Research|September 1, 1996
Mobilisation of blood progenitor cells with ifosfamide and etoposide (VP-16) in combination with recombinant human G-CSF (Filgrastim) in patients with malignant lymphomas or solid tumoursJ W Baars, M J Holtkamp, W J Nooyen, et al.
The Journal of Gene Medicine|September 11, 2002
Epidermal growth factor receptor targeting enhances adenoviral vector based suicide gene therapy of osteosarcomaM A Witlox, V W Van Beusechem, J Grill, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 23, 2018
Health-related quality of life analysis in stage III melanoma patients treated with adjuvant dendritic cell therapyM Bloemendal, M J A Rietveld, W W van Willigen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 18, 2024
Ipilimumab with nivolumab in molecularly selected patients with castration-resistant prostate cancer: primary analysis of the phase II INSPIRE trialS van Wilpe, I S H Kloots, P H J Slootbeek, et al.
Prostate Cancer and Prostatic Diseases|March 22, 2021
The effects of new life-prolonging drugs for metastatic castration-resistant prostate cancer (mCRPC) patients in a real-world populationH M Westgeest, M C P Kuppen, A J M van den Eertwegh, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Cancer Gene Therapy|July 31, 2001
Selective gene delivery toward gastric and esophageal adenocarcinoma cells via EpCAM-targeted adenoviral vectorsD A Heideman, P J Snijders, M E Craanen, et al.
Blood|November 15, 1995
The value of flow cytometric analysis of platelet glycoprotein expression of CD34+ cells measured under conditions that prevent P-selectin-mediated binding of plateletsM W Dercksen, I S Weimar, D J Richel, et al.
British Journal of Cancer|June 1, 2006
Different susceptibility of osteosarcoma cell lines and primary cells to treatment with oncolytic adenovirus and doxorubicin or cisplatinH C A Graat, M A Witlox, F H E Schagen, et al.
Anticancer Research|September 1, 1996
Mobilisation of blood progenitor cells with ifosfamide and etoposide (VP-16) in combination with recombinant human G-CSF (Filgrastim) in patients with malignant lymphomas or solid tumoursJ W Baars, M J Holtkamp, W J Nooyen, et al.
The Journal of Gene Medicine|September 11, 2002
Epidermal growth factor receptor targeting enhances adenoviral vector based suicide gene therapy of osteosarcomaM A Witlox, V W Van Beusechem, J Grill, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 23, 2018
Health-related quality of life analysis in stage III melanoma patients treated with adjuvant dendritic cell therapyM Bloemendal, M J A Rietveld, W W van Willigen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 18, 2024
Ipilimumab with nivolumab in molecularly selected patients with castration-resistant prostate cancer: primary analysis of the phase II INSPIRE trialS van Wilpe, I S H Kloots, P H J Slootbeek, et al.
Prostate Cancer and Prostatic Diseases|March 22, 2021
The effects of new life-prolonging drugs for metastatic castration-resistant prostate cancer (mCRPC) patients in a real-world populationH M Westgeest, M C P Kuppen, A J M van den Eertwegh, et al.
Pageof 6